Skip to main content

Our roundup of Canadian small-caps of between $100-million and $2.5-billion in market capitalization making news and on the move today.

Solium Capital Inc. (SUM-T) says it has an agreement to be bought by Morgan Stanley in an all-cash purchase of $19.15 per share, in a deal valued at approximately $1.1-billion. The shares closed at $13.36 on Friday, which is a 43-per-cent premium.

The arrangement requires the approval of two-thirds of Solium shareholders. All of the directors of Solium, who collectively own about 19 per cent of the shares, have signed agreements to vote in favour of the deal.

Story continues below advertisement

Calgary-based Solium provides stock plans for more than 3,000 companies including Shopify, Bombardier, and Dropbox.

**

DHX Media (DHX-T, DHXM-Q) announced it has signed a new exclusive agreement to bring new animated kids’ series Dorg Van Dango to Nickelodeon International.

Under the agreement, Dorg Van Dango will air exclusively on Nickelodeon International’s channels, including in the UK, Australia, Scandinavia, France, Italy, Spain, Central Eastern Europe, Poland, Israel, Latin America, Asia (excluding China), India, the Middle East and North Africa. Commissioning broadcaster Family Channel will air the new series in Canada, the company stated.

**

Trulieve Cannabis Corp. (TRUL-C) announced it has signed an agreement with Colorado-based Love’s Oven, LLC to bring their edible cannabis-infused baked goods, craft concentrates, and other products to Florida.

"Love's Oven specifically crafts their products to be the highest-quality available on the market and is dedicated to helping patients achieve relief from everything from chronic pain to insomnia and other ailments. Their products are not only delicious, they're clean, organic, and, most importantly, all natural, which is what Trulieve has focused on since the beginning," said Trulieve CEO Kim Rivers. "Their products are an effective, reliable treatment option for patients seeking relief in innovative ways."

Story continues below advertisement

**

Green Growth Brands Inc. (GGB-C) announced that it has an agreement that gives it access to 108 shop locations in U.S. malls owned and operated by the Simon Property Group, Inc. (SPG-N). Green Growth said it will further expand its chain of CBD-infused personal care product shops under the Seventh Sense Botanical Therapy brand and other GGB brands.

"Our partnership with Simon allows GGB to launch our brands and CBD products in premier shopping destinations across the U.S.," said Peter Horvath, CEO of GGB. The company said Simon is the largest shopping mall operator in the U.S.

**

TerrAscend Corp. (TER-C) said it signed a “definitive securities purchase agreements” to make a “significant investment” in three entities in California operating the dispensary brand known as “The Apothecarium.”

The company said the purchase agreements also include the acquisitions of an operation in Nevada with cultivation, edible manufacturing and an Apothecarium retail location, as well as Valhalla Confections, a provider of leading premium edible products.

Story continues below advertisement

"Today's news is another major step in executing TerrAscend's US strategy," stated Matthew Johnson, president of TerrAscend.

**

Hudson’s Bay Corp. (HBC-T) announced it has closed the sale of the Lord & Taylor Fifth Avenue building to WeWork Property Investors (WPI) for $1.1-billion.

“This transaction reinforces HBC’s ability to identify undervalued real estate investments with great potential,” said Richard Baker, HBC’s governor and executive chairman. “We continue to strengthen our retail business and unlock the value of our real estate assets.”

With the closing of this transaction, HBC said it has eliminated the approximately $520-million Lord & Taylor mortgage and has reduced borrowings under its asset-based revolving facility.

Report an error Editorial code of conduct
Tickers mentioned in this story
Unchecking box will stop auto data updates
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

Cannabis pro newsletter